SALVAGE THERAPY WITH MYCOPHENOLATE MOFETIL FOR LUNG TRANSPLANT BRONCHIOLITIS OBLITERANS
- 1 August 1997
- journal article
- case report
- Published by Wolters Kluwer Health in Transplantation
- Vol. 64 (3), 533-535
- https://doi.org/10.1097/00007890-199708150-00027
Abstract
Bronchiolitis obliterans (BO) is the most important long-term complication of lung transplantation. Treatment of this condition is often unsuccessful. A patient presented with early BO. Despite OKT3 and the addition of methotrexate, the patient needed persistently high doses of prednisone to maintain lung function at a moderate level. Only the substitution of azathioprine by mycophenolate mofetil (MMF, 3 g/day) made it possible to reduce the dose of prednisone. Reduction of the dose of MMF to 2 g/day resulted in a deterioration of lung function, which improved impressively after MMF was increased again to 3 g/day. MMF may be a valuable therapy for lung transplant BO. However, the use of a high dose, i.e., 3 g/day, may be crucial.Keywords
This publication has 9 references indexed in Scilit:
- Prospective study of the value of transbronchial lung biopsy after lung transplantationEuropean Respiratory Journal, 1996
- Aerosolized cyclosporine in lung recipients with refractory chronic rejection.American Journal of Respiratory and Critical Care Medicine, 1996
- CYTOLYTIC THERAPY FOR THE TREATMENT OF BRONCHIOLITIS OBLITERANS SYNDROME FOLLOWING LUNG TRANSPLANTATIONTransplantation, 1996
- Obliterative bronchiolitis after lung and heart-lung transplantationThe Annals of Thoracic Surgery, 1995
- MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1995
- Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejectionThe Lancet, 1995
- Pulmonary retransplantation for obliterative bronchiolitis:The Journal of Thoracic and Cardiovascular Surgery, 1994
- The Role of Transbronchial Lung Biopsy in the Treatment of Lung Transplant RecipientsChest, 1992
- RISK FACTORS FOR OBLITERATIVE BRONCHIOLITIS IN HEART-LUNG TRANSPLANT RECIPIENTSTransplantation, 1991